That put the shares at their lowest level in almost seven years, even though the punitive damages award is likely to be reduced due to US Supreme Court rulings that limit the ratio of punitive to compensatory damages to 9:1. Bayer on Monday said in a statement that it was disappointed with the verdict and would appeal. Bayer, inventor of Aspirin and maker of stroke prevention drug Xarelto and Yasmin birth control pills, faces US lawsuits from more than 13,400 plaintiffs over the herbicide’s alleged cancer risk. The European Chemicals Agency and other regulators around the globe have also found glyphosate not likely to be carcinogenic to humans. However, the WHO’s International Agency for Research on Cancer concluded in 2015 that the chemical probably causes cancer.

Source: Taipei Times May 14, 2019 15:56 UTC